Results 11 to 20 of about 10,606 (259)

Displacement of impella post chest compressions

Heart Views, 2014
The Impella is a left ventricular assist device which is implanted via the transcutaneous femoral route and is placed across the aortic valve into the left ventricle.
Sourabh Aġġarwal, Susan Bannon
doaj   +4 more sources

The intelligent Impella: Future perspectives of artificial intelligence in the setting of Impella support

ESC Heart Failure
Aims Artificial intelligence (AI) has emerged as a potential useful tool to support clinical treatment of heart failure, including the setting of mechanical circulatory support (MCS).
Filippo Consolo, Jacopo D'Andria Ursoleo, Marina Pieri, Pasquale Nardelli, Lorenzo Cianfanelli, Vittorio Pazzanese, Silvia Ajello, Anna Mara Scandroglio   +7 more
doaj   +3 more sources

Weaning from Impella and mobilization of Impella patients [PDF]

European Heart Journal Supplements, 2021
AbstractWeaning of patients from Impella is complex and includes evaluation of the underlying disease, which is essential for estimating the potential for heart recovery. Monitoring during the weaning phase with echocardiography and pulmonary artery catheters will be discussed, as well as the use of intravenous and oral heart failure drugs.
Andrea Montisci, Federico Pappalardo, Clément Delmas, Letizia Bertoldi   +3 more
openaire   +3 more sources

Complications Leading to Death in Patients Supported by the Impella 5.5: Analysis From the FDA MAUDE Database. [PDF]

Catheter Cardiovasc Interv
ABSTRACT Background The Impella 5.5 is increasingly being used in patients with cardiogenic shock, but experience with the device remains limited, and severe complications, including death, have been reported. This study aims to investigate causes of Impella 5.5‐related deaths.
Khalil O, Krayem H, Kesari A, Mahtani AU, Kaye MG, Roberts C, Tchoukina I, Smallfield MC, Chery J, Hashmi ZA, Kontos MC, Shah KB, Li P.   +12 more
europepmc   +2 more sources

Impella insertion for residual aortic dissection [PDF]

Clinical Case Reports, 2021
Acute aortic dissection with coronary malperfusion is a life-threatening disease, resulting in demanding postoperative management. We report a successful insertion of percutaneous heart pump Impella through the intact true lumen in a patient with residual aortic dissection after the graft replacement and its recovery from the post-cardiotomy ...
Hisashi Yoshida, Yuki Ichihara, Ryogo Hoki, Hiroshi Niinami   +3 more
openaire   +4 more sources

A Review of the Impella Devices

Interventional Cardiology: Reviews, Research, Resources, 2022
The use of mechanical circulatory support (MCS) to provide acute haemodynamic support for cardiogenic shock or to support high-risk percutaneous coronary intervention (HRPCI) has grown over the past decade. There is currently no consensus on best practice regarding its use in these two distinct indications.
Rami Zein, Chirdeep Patel, Adrian Mercado-Alamo, Theodore Schreiber, Amir Kaki   +4 more
openaire   +3 more sources

Thrombocytopenia with Impella: Not a HIT

Catheterization and Cardiovascular Interventions, 2023
Key Points The Impella percutaneous microaxial ventricular assist device provides significant ventricular unloading, but at the cost of increased major bleeding, hemolysis, and thrombocytopenia. The present study shows that nearly all patients develop thrombocytopenia within 7 days of Impella insertion with 81% having a >50% decrease.
Arnold H. Seto, Morton J. Kern
openaire   +2 more sources

Percutaneous Salvage of an Impella Pretzel

JACC: Case Reports, 2019
This report describes a case in which bedside manipulation of an Impella CP led to device entanglement in the aorta. Using a snare and counter-traction, we were able to untangle and re-deliver it into the left ventricle to restore normal device support. (Level of Difficulty: Advanced.).
Moses Mathur, Adam Mohmand-Borkowski, Mariko W. Harper, Gordon L. Kritzer   +3 more
openalex   +5 more sources

Impella-Supported Cardiac Surgery [PDF]

Interventional Cardiology, 2020
Background: Impella left ventricular assist devices are useful tools for the treatment of cardiogenic shock. The peri-operative use of Impella in patients with low left ventricular ejection fraction (LVEF) undergoing cardiac surgery, can be valuable for cardiac surgeons to prevent postcardiotomy cardiogenic shock. Methods: From September 2018
Masiello, Paolo, Mastrogiovanni, Generoso, Colombino, Mario, Cafarelli, Francesco, Frunzo, Francesco, Padula, Marco, Triggiani, Donato, Negro, Gerardo Del, Fiore, Emanuele, Iesu, Severino   +9 more
openaire   +2 more sources

A case of left ventricular free wall rupture after insertion of an IMPELLA® left ventricular assist device diagnosed by transesophageal echocardiography

JA Clinical Reports, 2021
Background The IMPELLA® is a minimally invasive left ventricular assist device. We report a case in which transesophageal echocardiography (TEE) was useful in diagnosis of left ventricular rupture after IMPELLA® insertion. Case presentation A 75-year-old
Akito Mizuno, Shuji Kawamoto, Shuji Uda, Kenichiro Tatsumi, Chikashi Takeda, Tomoharu Tanaka, Kazuhiko Fukuda   +6 more
doaj   +1 more source